Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (1166)	9/16/1998 9:52:00 AM
From: chirodoc	Respond to of 10280

listened to ceo he sounded sharp only negative: when they asked him what would prevent a big pharma from using the same drug discovery process imho he was a bit evasive that is the only negative as far as i could see curtis

To: RCMac who wrote (1166)	9/16/1998 10:13:00 AM
From: David Howe	Read Replies (1) \| Respond to of 10280

The interview went well. I didn't know that their Claritin ICE was in phase III. He also confirmed that Levalbuteral should receive labeling approval "this month". The speed with which they bring product to market is amazing. SEPR has hit the resistance in the 55 - 56 area that I anticipated. I sold my trading shares. The market might also be nearing the high end of a trading range. I'm cautiously bullish. We should see additional news within the next few weeks. Dave